alendronate has been researched along with Cirrhosis in 7 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In our previous study, farnesyl pyrophosphate synthase (FPPS) was shown to be increased in spontaneously hypertensive rats (SHR) and in mice with angiotensin-II induced cardiac hypertrophy." | 3.83 | Alteration of RhoA Prenylation Ameliorates Cardiac and Vascular Remodeling in Spontaneously Hypertensive Rats. ( Chen, YN; Mou, Y; Xu, ZX; Yang, J; Zheng, LR, 2016) |
| "The alendronate or saline was administered subcutaneously 1 week prior to surgery, immediately prior to surgery, and 1 week after surgery." | 1.32 | A histopathological investigation on the effect of systemic administration of the bisphosphonate alendronate on resorptive phase following mucoperiosteal flap surgery in the rat mandible. ( Bostanci, H; Günhan, O; Kaynak, D; Meffert, R; Ozkaya, OG, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Harata, S | 1 |
| Kasukawa, Y | 1 |
| Nozaka, K | 1 |
| Tsuchie, H | 1 |
| Shoji, R | 1 |
| Igarashi, S | 1 |
| Kasama, F | 1 |
| Oya, K | 1 |
| Okamoto, K | 1 |
| Miyakoshi, N | 1 |
| Ye, Y | 3 |
| Lv, X | 1 |
| Wang, MH | 1 |
| Zhu, J | 1 |
| Chen, SQ | 1 |
| Jiang, CY | 1 |
| Fu, GS | 1 |
| Yang, J | 2 |
| Chen, YN | 1 |
| Xu, ZX | 1 |
| Mou, Y | 2 |
| Zheng, LR | 1 |
| Li, L | 1 |
| Chen, GP | 2 |
| Yang, Y | 1 |
| Yao, L | 1 |
| Hu, SJ | 2 |
| Chesnick, IE | 1 |
| Fowler, CB | 1 |
| Mason, JT | 1 |
| Potter, K | 1 |
| Zhu, HH | 1 |
| Zhao, CZ | 1 |
| Kaynak, D | 1 |
| Meffert, R | 1 |
| Bostanci, H | 1 |
| Günhan, O | 1 |
| Ozkaya, OG | 1 |
7 other studies available for alendronate and Cirrhosis
| Article | Year |
|---|---|
Effects of bisphosphonates and treadmill exercise on bone and kidney in adenine-induced chronic kidney disease rats.
Topics: Aged; Alendronate; Animals; Bone Density; Bone Density Conservation Agents; Diphosphonates; Fibrosis | 2023 |
Alendronate prevents angiotensin II-induced collagen I production through geranylgeranylation-dependent RhoA/Rho kinase activation in cardiac fibroblasts.
Topics: Alendronate; Angiotensin II; Animals; Cells, Cultured; Collagen Type I; Depression, Chemical; Diterp | 2015 |
Alteration of RhoA Prenylation Ameliorates Cardiac and Vascular Remodeling in Spontaneously Hypertensive Rats.
Topics: Alendronate; Animals; Aorta; Blood Pressure; Bone Density Conservation Agents; Cardiomegaly; Collage | 2016 |
Chronic inhibition of farnesyl pyrophosphate synthase attenuates cardiac hypertrophy and fibrosis in spontaneously hypertensive rats.
Topics: Alendronate; Animals; Cardiomegaly; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibrosis; G | 2010 |
Novel mineral contrast agent for magnetic resonance studies of bone implants grown on a chick chorioallantoic membrane.
Topics: Alendronate; Animals; Bone and Bones; Bone Substitutes; Chickens; Chorioallantoic Membrane; Contrast | 2011 |
Inhibition of farnesyl pyrophosphate synthase attenuates angiotensin II-induced cardiac hypertrophy and fibrosis in vivo.
Topics: Alendronate; Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Contraindications; Fi | 2013 |
A histopathological investigation on the effect of systemic administration of the bisphosphonate alendronate on resorptive phase following mucoperiosteal flap surgery in the rat mandible.
Topics: Alendronate; Alveolar Bone Loss; Alveolar Process; Animals; Bone Resorption; Chi-Square Distribution | 2003 |